Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Young

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapyElizabeth T Golub, Lorie Benning, Anjali Sharma, et al.
Expert Review of Anticancer Therapy|July 30, 2021
A new prognostic model for predicting 30-day mortality in acute oncology patientsTess O'Neill, Mohammed T Hudda, Reena Patel, et al.
AIDS (London, England)|April 20, 2004
Healthcare use by varied highly active antiretroviral therapy (HAART) strata: HAART use, discontinuation, and naivetyHerminia Palacio, Xiuhong Li, Tracey E Wilson, et al.
Journal of AIDS & Clinical Research|June 27, 2014
Microvascular Endothelial Dysfunction and Enhanced Thromboxane and Endothelial Contractility in Patients with HIVDan Wang, Joseph K Melancon, Jennifer Verbesey, et al.
AIDS Research and Therapy|July 8, 2010
The identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patientsRachel Van Duyne, Irene Guendel, Kylene Kehn-Hall, et al.
AIDS Research and Therapy|December 31, 2013
Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort studyChenglong Liu, Cuiwei Wang, Marshall J Glesby, et al.
Annals of Internal Medicine|February 19, 2004
The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapyKathryn Anastos, Yolanda Barrón, Mardge H Cohen, et al.
The American Journal of Medicine|July 23, 2002
Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapyMardge H Cohen, Audrey L French, Lorie Benning, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2012
Association of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetesPhyllis C Tien, Michael F Schneider, Christopher Cox, et al.
AIDS (London, England)|September 28, 2010
HIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV StudyPhyllis C Tien, Michael F Schneider, Christopher Cox, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapyElizabeth T Golub, Lorie Benning, Anjali Sharma, et al.
Expert Review of Anticancer Therapy|July 30, 2021
A new prognostic model for predicting 30-day mortality in acute oncology patientsTess O'Neill, Mohammed T Hudda, Reena Patel, et al.
AIDS (London, England)|April 20, 2004
Healthcare use by varied highly active antiretroviral therapy (HAART) strata: HAART use, discontinuation, and naivetyHerminia Palacio, Xiuhong Li, Tracey E Wilson, et al.
Journal of AIDS & Clinical Research|June 27, 2014
Microvascular Endothelial Dysfunction and Enhanced Thromboxane and Endothelial Contractility in Patients with HIVDan Wang, Joseph K Melancon, Jennifer Verbesey, et al.
AIDS Research and Therapy|July 8, 2010
The identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patientsRachel Van Duyne, Irene Guendel, Kylene Kehn-Hall, et al.
AIDS Research and Therapy|December 31, 2013
Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort studyChenglong Liu, Cuiwei Wang, Marshall J Glesby, et al.
Annals of Internal Medicine|February 19, 2004
The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapyKathryn Anastos, Yolanda Barrón, Mardge H Cohen, et al.
The American Journal of Medicine|July 23, 2002
Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapyMardge H Cohen, Audrey L French, Lorie Benning, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2012
Association of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetesPhyllis C Tien, Michael F Schneider, Christopher Cox, et al.
AIDS (London, England)|September 28, 2010
HIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV StudyPhyllis C Tien, Michael F Schneider, Christopher Cox, et al.
Pageof 17